Prestige Consumer Healthcare Inc
Change company Symbol lookup
Select an option...
PBH Prestige Consumer Healthcare Inc
EPAM Epam Systems Inc
ISLE Isleworth Healthcare Acquisition Corp
TRMD Torm PLC
THC Tenet Healthcare Corp
BKCC BlackRock Capital Investment Corp
VIR Vir Biotechnology Inc
CBH Virtus Convertible & Income 2024 Target Term Fund
PSX Phillips 66
RGT Royce Global Value Trust
Go

Health Care : Pharmaceuticals | Small Cap Blend
Company profile

Prestige Consumer Healthcare Inc. is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. The Company operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its brands include BC/Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Fleet, Gaviscon, Luden's, Monistat, Nix, TheraTears, Summer's Eve, Fess and Hydralyte. Its subsidiaries include Blacksmith Brands, Inc., C.B. Fleet Company, Incorporated, Care Pharmaceuticals Pty Limited, DenTek Holdings, Inc., Medtech Holdings, Inc., Peaks HBC Company, Inc. and others.

Price
Delayed
$59.60
Day's Change
-0.18 (-0.30%)
Bid
--
Ask
--
B/A Size
--
Day's High
59.60
Day's Low
59.60
Volume
1,885

PBH's position in the Pharmaceuticals industry

Industry PeersPBHJNJAMPHSUPNAMRX

Summary

Company ProfilePrestige Consumer Healthcare Inc. is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers...
Johnson & Johnson is a holding company that is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates through three...
Go to JNJ summary
Amphastar Pharmaceuticals, Inc. is a bio-pharmaceutical company. The Company is primarily focused on developing, manufacturing, marketing and selling generic and injectable, inhalation, and...
Go to AMPH summary
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The...
Go to SUPN summary
Amneal Pharmaceuticals, Inc. is a pharmaceutical company. The Company specializes in developing, manufacturing, marketing and distributing generic and branded specialty pharmaceutical products. It...
Go to AMRX summary
52-Week Change

VS. INDUSTRY
14.52%
5.42%
68.17%
-1.88%
-35.41%
Market Cap

VS. INDUSTRY
$3.0B
$468.8B
$1.7B
$1.6B
$1.0B
Beta

VS. INDUSTRY
0.5
0.6
0.7
1.0
1.2
Dividend Yield

VS. INDUSTRY
--
2.54%
--
--
--
P/E (TTM, GAAP)

VS. INDUSTRY
14.80x
23.99x
21.54x
23.06x
326.77x
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$1.1B
$94.9B
$455.1M
$601.3M
$2.1B
Profit Margin

VS. INDUSTRY
18.90%
20.90%
18.57%
12.20%
-0.04%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
25.44%
5.65%
43.27%
-11.04%
--
Revenue Growth (TTM)

VS. INDUSTRY
15.21%
12.67%
23.61%
8.09%
5.59%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.